- Pharmacology in Airway Diseases
-
Kim KH
- KMID: 2318775
- Tuberc Respir Dis.
- 2006 Jan;60(1):21-37.
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- New Antimicrobial Agents in Respiratory Medicine
-
Chung MH
- KMID: 2318774
- Tuberc Respir Dis.
- 2006 Jan;60(1):5-20.
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Antiinflammatory Effects of Heparin in Hemorrhage or LPS Induced Acute Lung Injury
-
Kim JY, Choi JC, Lee YW, Jung JW, Shin JW, Park IW, Choi BW
- KMID: 2318778
- Tuberc Respir Dis.
- 2006 Jan;60(1):49-56.
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Hepatotoxicity of Rifampicin and Pyrazinamide Treatment Excluding Isoniazid
-
Choi IS, Park IN, Hong SB, Oh YM, Lim CM, Lee SD, Koh Y, Kim WS, Kim DS, Kim WD, Shim TS
- KMID: 2318776
- Tuberc Respir Dis.
- 2006 Jan;60(1):38-43.
BACKGROUND: Even though two-month rifampicin (RMP, R) and pyrazinamide (PZA, P) treatment has some advantages over isoniazid (INH, H) treatment for latent tuberculosis infection (LTBI), it was withdrawn from the... -
- CITED
-
- Close
- SHARE
-
- Close
- Disseminated Coccidioidomycosis Presenting with Miliary Nodules
-
Kim JH, Hur GY, Jung KH, Jung HC, Park DW, Lee SY, Lee SY, Kim JH, Shon JU, Shin C, Shim JJ, In KH, Kang KH, Yoo SH
- KMID: 2318785
- Tuberc Respir Dis.
- 2006 Jan;60(1):97-101.
Coccidioidomycosis is a rare systemic fungal infection in Korea. However, the incidence of coccidioidomycosis has recently begun to increase due to the increasing incidence of people traveling overseas to endemic... -
- CITED
-
- Close
- SHARE
-
- Close
- Risk Factors of Recurrent Hemoptysis after Bronchial Artery Embolization
-
Chung WY, Byun MK, Park MS, Hahn CH, Kang SM, Lee DY, Kim YS, Kim SK, Kim SK, Chang J
- KMID: 2318780
- Tuberc Respir Dis.
- 2006 Jan;60(1):65-71.
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Comparison of Effectiveness and Adverse Reactions between Isoniazid 300 mg and 400 mg in Korean Patients with Pulmonary Tuberculosis
-
Park IN, Hong SB, Oh YM, Lim CM, Lee SD, Koh Y, Kim WS, Kim DS, Kim WD, Shim TS
- KMID: 2318777
- Tuberc Respir Dis.
- 2006 Jan;60(1):44-48.
BACKGROUND: Isoniazid (INH) is one of the most effective anti-tuberculosis (TB) drugs. In Korea, the dose of INH normally used in patients over 50 kg is 400 mg/day, which differs... -
- CITED
-
- Close
- SHARE
-
- Close
- Effects of Aspirin on the Pathogenesis of Acute Lung Injury in Rats Subjected to Hemorrhage
-
Park YY, Lee YM
- KMID: 2318783
- Tuberc Respir Dis.
- 2006 Jan;60(1):83-91.
BACKGROUND: For unknown reasons, the serum ferritin concentrations are higher in patients with acute lung injury. A pretreatment with aspirin reduces the acute lung injury in rats subjected severe hemorrhage,... -
- CITED
-
- Close
- SHARE
-
- Close
- Benign Metastasizing Pulmonary Leiomyoma with Hemoptysis
-
Park SY, Lim EJ, Jang JS, Kim CH, Jee HK, Cho SJ, Park YB, Lee JY, Mo EK
- KMID: 2318784
- Tuberc Respir Dis.
- 2006 Jan;60(1):92-96.
A benign metastasizing pulmonary leiomyoma(BMPL) is a rare disease that is usually detected years after a hysterectomy or myomectomy. Despite the benign pathological appearance, these tumors can metastasize and become... -
- CITED
-
- Close
- SHARE
-
- Close
- Efficacious Pleurodesis with OK-432 Plus Autoblood or OK-432 Against the Pneumothorax with Persistent Air Leak
-
Kim HS, Choi GM
- KMID: 2318781
- Tuberc Respir Dis.
- 2006 Jan;60(1):72-75.
BACKGROUND: This report reviews our experience with persistent air leaks in the peumothorax that were not considered candidates for surgical treatment in order to evaluate the efficacy and risks of... -
- CITED
-
- Close
- SHARE
-
- Close
- Analysis of Sleep Questionnaires of Patients who Performed Overnight Polysomnography at the University Hospital
-
Kang JH, Lee SH, Kwon SS, Kim YK, Kim KH, Song JS, Park SH, Moon HS, Park YM
- KMID: 2318782
- Tuberc Respir Dis.
- 2006 Jan;60(1):76-82.
BACKGROUND: The objective of this study was to understand sleep-related problems, and to determine whether the sleep questionnaires is a clinically useful method in patients who need polysomnography. METHODS: Subjects were... -
- CITED
-
- Close
- SHARE
-
- Close
- Phase II Trial of Irinotecan plus Cisplatin Combination as First Line Therapy for Patients with Small cell Lung Cancer
-
Jeong HC, Lee SY, Kim JH, Ha ES, Jung JY, Lee KJ, Lee SH, Kim SJ, Lee EJ, Hur GY, Lee SY, Kim JH, Shin C, Shim JJ, In KH, Kang KH, Yoo SH
- KMID: 2318779
- Tuberc Respir Dis.
- 2006 Jan;60(1):57-64.
BACKGROUND: Recently, there have been several studies showing that irinotecan hydrochloride, a topoisomerase I inhibitor, is effective against extensive disease(ED) small cell lung cancer (SCLC). We conducted a phase II... -
- CITED
-
- Close
- SHARE
-
- Close
